PRICE T ROWE ASSOCIATES INC /MD/
Position in KYMR — Kymera Therapeutics, Inc.
CIK 80255
BALTIMORE, MD
Position in KYMR
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$815,645,416
+$310,837,470 QoQ
Shares Held
7,112,980
+17.4% QoQ
Ownership
8.55%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#4
of 273 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in KYMR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PRICE T ROWE ASSOCIATES INC /MD/ holds $17,555,963,376 across 304 Biotechnology names. KYMR ranks #4 (4.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
2,678,047 | $2,484,611,664 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,529,709 | $953,834,749 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,728,421 | $858,558,562 | |
| 4 | KYMR |
Kymera Therapeutics, Inc.
This page
|
7,112,980 | $815,645,416 | |
| 5 | RPRX |
Royalty Pharma plc
|
11,193,657 | $627,628,347 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
2,969,853 | $447,655,945 | |
| 7 | MRNA |
Moderna, Inc.
|
5,589,560 | $391,436,886 | |
| 8 | SRRK |
Scholar Rock Holding Corp
|
6,794,837 | $373,716,035 |
All Filings in KYMR
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $815,572,601 | 7,112,345 | Shares | Sole | 2026-08-14 | |
| 2026-06-30 | $815,645,416 | 7,112,980 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $504,807,946 | 6,060,847 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $479,257,855 | 6,159,335 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $288,511,594 | 5,097,378 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $299,335,574 | 6,859,202 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $183,446,056 | 6,702,450 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $276,393,496 | 6,870,333 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $314,530,283 | 6,645,474 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $190,761,140 | 6,390,658 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $254,546,882 | 6,332,012 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $135,847,226 | 5,335,712 | Shares | Sole | 2024-02-16 | |
| 2023-09-30 | $70,298,207 | 5,057,425 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $115,114,332 | 5,007,148 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $138,273,757 | 4,666,681 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $109,303,808 | 4,379,159 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $89,207,189 | 4,097,712 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $102,874,067 | 5,224,686 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $164,845,075 | 3,895,205 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $225,423,022 | 3,550,528 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $189,917,991 | 3,233,197 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $89,478,911 | 1,844,926 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $36,255,525 | 932,978 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $24,308,712 | 392,076 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $9,521,595 | 294,695 | Shares | Sole | 2020-11-16 | |
| No filing history on record for this holder in this stock. | ||||||